Arcellx, Inc. Files 8-K Report

Ticker: ACLX · Form: 8-K · Filed: Dec 12, 2024 · CIK: 1786205

Arcellx, INC. 8-K Filing Summary
FieldDetail
CompanyArcellx, INC. (ACLX)
Form Type8-K
Filed DateDec 12, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, SEC Filing, Corporate Update

TL;DR

Arcellx filed an 8-K on Dec 12th for events on Dec 9th. Standard corporate update.

AI Summary

Arcellx, Inc. filed an 8-K on December 12, 2024, reporting other events and financial statements/exhibits. The filing date for the report was December 9, 2024. The company is incorporated in Delaware and its principal executive offices are located in Redwood City, CA.

Why It Matters

This 8-K filing indicates that Arcellx, Inc. has submitted important corporate and financial information to the SEC, which could include updates on business operations or financial performance.

Risk Assessment

Risk Level: low — This filing is a routine 8-K for reporting events and exhibits, not indicating any immediate material adverse changes.

Key Numbers

Key Players & Entities

FAQ

What specific 'Other Events' are being reported by Arcellx, Inc. in this 8-K filing?

The provided text does not detail the specific 'Other Events' but indicates that this item is included in the filing.

What is the significance of the 'Financial Statements and Exhibits' being filed?

This indicates that Arcellx, Inc. is providing updated financial information or relevant supporting documents as part of this report.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on December 9, 2024.

What is Arcellx, Inc.'s standard industrial classification?

Arcellx, Inc.'s standard industrial classification is BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836].

Where are Arcellx, Inc.'s principal executive offices located?

Arcellx, Inc.'s principal executive offices are located at 800 Bridge Parkway, Redwood City, CA 94065.

Filing Stats: 455 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-12-11 17:45:48

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Arcellx, Inc. Corporate Presentation. 104 Cover Page Interactive Data File (formatted as Inline XBRL).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ARCELLX, INC. Date: December 11, 2024 By: /s/ Rami Elghandour Rami Elghandour Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing